Dr Roger Dale Graben, RPH, PHD is a
Pharmacist - Pharmacotherapy based in Lineville, Alabama. Dr Roger Dale Graben is licensed to practice in Alabama (license number 10883) and his current practice location is
438 E Mill Rd, Lineville, Alabama. He can be reached at his office (for appointments etc.) via phone at
(256) 239-9373.
NPI number for Dr Roger Dale Graben is 1780894196 and his current mailing address is 438 E Mill Rd, Lineville, Alabama. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1780894196.
Healthcare Provider's Profile
Full Name | Dr Roger Dale Graben |
---|
Gender | Male |
---|
Speciality | Pharmacist - Pharmacotherapy |
---|
Location | 438 E Mill Rd, Lineville, Alabama |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
NPI Data:
- NPI Number: 1780894196
- Provider Enumeration Date: 05/23/2007
- Last Update Date: 07/08/2007
Medical Identifiers
Medical identifiers for Dr Roger Dale Graben such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1780894196 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
183500000X | Pharmacist | 10883 (Alabama) | Primary |
1835P1200X | Pharmacist - Pharmacotherapy | 10883 (Alabama) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Roger Dale Graben is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Dr Roger Dale Graben, RPH, PHD 438 E Mill Rd, Lineville, AL 36266-3608 Ph: (256) 239-9373 | Dr Roger Dale Graben, RPH, PHD 438 E Mill Rd, Lineville, AL 36266-3608 Ph: (256) 239-9373 |
Reviews and Comments